Literature DB >> 9240688

Predictions for future human influenza pandemics.

R G Webster1.   

Abstract

Will there be another human influenza pandemic? The certainty is that there will be, and the probability is that the virus will emerge from Eurasian aquatic bird reservoirs and involve reassortment between a human and avian strain, with accumulation of mutations or true recombinational events (or both) that will permit spread and pathogenicity among humans. This process will probably occur in pigs because they possess receptors for both avian and human influenza viruses, and emergence may occur in southern China. Prediction of the subtype is impossible, but there is a hypothesis based on seroarcheology that only H1, H2, and H3 subtypes can infect humans; however, it is arguable that H7 or H2 strains might be equally capable of infecting humans.

Entities:  

Mesh:

Year:  1997        PMID: 9240688     DOI: 10.1086/514168

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

1.  Vaccinate for the next H2N2 pandemic now.

Authors:  Gary J Nabel; Chih-Jen Wei; Julie E Ledgerwood
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

2.  Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.

Authors:  Vasiliy P Mishin; Frederick G Hayden; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals.

Authors:  I A Leneva; O Goloubeva; R J Fenton; M Tisdale; R G Webster
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 4.  Extracorporeal life support for pandemic influenza: the role of extracorporeal membrane oxygenation in pandemic management.

Authors:  Ed DeLaney; Michael J Smith; Brian T Harvey; Keith J Pelletier; Michael P Aquino; Justin M Stone; Gerald C Jean-Baptiste; Julie H Johnson
Journal:  J Extra Corpor Technol       Date:  2010-12

5.  Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Randy Albrecht; David L Blum; Irene Ramos; Ana Fernandez-Sesma; Kathryn M Edwards; Adolfo García-Sastre; Christopher F Basler; James E Crowe
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

6.  Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates.

Authors:  Andrew J Broadbent; Celia P Santos; Myeisha Paskel; Yumiko Matsuoka; Janine Lu; Zhongying Chen; Hong Jin; Kanta Subbarao
Journal:  Vaccine       Date:  2014-11-06       Impact factor: 3.641

7.  Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic.

Authors:  Rui Xu; Ryan McBride; James C Paulson; Christopher F Basler; Ian A Wilson
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

8.  DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice.

Authors:  S Kodihalli; H Goto; D L Kobasa; S Krauss; Y Kawaoka; R G Webster
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Protection against a lethal avian influenza A virus in a mammalian system.

Authors:  J M Riberdy; K J Flynn; J Stech; R G Webster; J D Altman; P C Doherty
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999.

Authors:  Timothy M Uyeki; Yu-Hoi Chong; Jacqueline M Katz; Wilina Lim; Yuk-Yin Ho; Sophia S Wang; Thomas H F Tsang; Winnie Wan-Yee Au; Shuk-Chi Chan; Thomas Rowe; Jean Hu-Primmer; Jensa C Bell; William W Thompson; Carolyn Buxton Bridges; Nancy J Cox; Kwok-Hang Mak; Keiji Fukuda
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.